Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Key Sessions

Hubert Birner

Keynote Chat: Navigating VC Investment, Focus, & Trends

TVM Capital Life Science

Mar 24
Show Filter
09:00 - 10:00 60 mins
Registration and Networking Breakfast
10:00 - 10:15 15 mins
Opening Remarks

Wendy Nelson, CEO, LeadingBiotech

10:15 - 10:45 30 mins
Shifting the Paradigm; Encouraging a Culture of Entrepreneurship in Europe’s Biotech Industry
  • Annalisa Jenkins - CEO, PlaqueTec Ltd
  • Don deBethizy - Chairman, Albumedix
  • Nathalie Rowell - CEO, Virdis Group

What kind of people are needed to make a successful, sustainable biotech? What changes are needed to encourage, recruit and retain a robust life science community throughout Europe?

11:15 - 11:45 30 mins
Public Markets: What are the Implications of Listing in Europe vs the US
  • Adam Kostyál - SVP - Head of Listings EMEA, Nasdaq

Look at the difference between going public in Europe vs the US for European-based biotech companies, current trends, and the implications for listing

11:45 - 12:15 30 mins
Networking Break
12:15 - 12:45 30 mins
Avoiding the Pitfalls in Pharma Partnerships & Deal Making
  • Miriam Frieden - Vice President R&D Innovation Sourcing, Novo Nordisk

What are the elements of a successful partnership, and what lessons can be learned to avoid often overlooked mis-steps?

12:45 - 13:15 30 mins
Creating Long Term Value and Innovation in European Life Sciences
  • Soren Moller - Managing Partner, Novo Seeds

How are stakeholders acting towards creating long term value in the life science community in Europe? How must biotech builders think about their path forward, from compelling science to commercial strategy? 

13:15 - 13:45 30 mins
Fireside Chat: Building a Biotech in Europe

What are some of the valuable growth strategies and survival techniques in the early stages of biotech development? Hear other biotech perspectives from peers in various stages of growth and development.

13:45 - 14:45 60 mins
Networking Lunch
14:45 - 15:15 30 mins
Investor/Founder Origin Story
  • Jasper Bos - Senior Vice President, Head of the Healthcare Fund, M Ventures
  • Francois Conquet - Founder & CEO, Prexton Therapeutics

Gain candid insight via a remarkable story of Merck spin-off Prexton Therapeutics, including a fascinating exit with the 2018 sale of the company to Lundbeck.

15:15 - 15:45 30 mins
Oncology Pipeline: The Path to Drug Development

Asses the latest developments in Oncology from Cell & Gene Therapy, technology enabling Precision Medicine to the latest in CarT & Immunotherapy. What kind of evidence do you need for regulatory approval, to bring an oncology treatment to market in Europe?

15:45 - 16:00 15 mins
Spotlight: Making an Exit
  • Jonas Hansson - Senior Advisor, Alexion Pharmaceuticals

In April 2018, Alexion Pharmaceuticals announced an acquisition of a biopharmaceutical company based in Stockholm, Sweden. Sit in for a special “exit story” told by former Founder & CEO of Wilson Pharma

16:00 - 16:30 30 mins
Networking Break
16:30 - 17:00 30 mins
Moderated Keynote Chat
17:00 - 17:30 30 mins
The Future of European Biotech in a Global Setting
  • Thomas Lonngren - Former Executive Director, EMA
  • Kevin Lee - CEO, Bicycle Therapeutics
  • John Haurum - Fmr. CEO, F-Star

What are the key success factors to compete in a global market? Take a closer look at Europe in the context of the “big picture”  

17:30 - 17:45 15 mins
Closing Remarks
17:45 - 18:45 60 mins
Cocktail Reception & Networking